Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Patients With Relapsed/Refractory Multiple Myeloma
暂无分享，去创建一个
S. Jagannath | A. Jakubowiak | N. Munshi | P. Hari | J. Goldberg | A. Lesokhin | A. Stewart | D. Madduri | Yi Lin | A. Deol | L. Pacaud | A. Allred | E. Zudaire | S. Usmani | A. Cohen | D. Avigan | T. Martin | T. Yeh | Jordan M. Schecter | W. Deraedt | J. Berdeja | Carolyn C. Jackson | Y. Olyslager | M. Agha | M. Htut | A. Banerjee | Changwei Zhou | E. O’Donnell | A. Stewart | Jordan Schecter